Patents Assigned to ZHEJIANG KANGLAITE PHARMACEUTICAL CO., LTD.
  • Publication number: 20160015672
    Abstract: The present invention relates to a pharmaceutical composition containing 13 compounds: 1,3-diolein, 1-linolein-3-olein, 1,2-diolein, 1-olein-2-linolein, 1,2-dilinolein, trilinolein, 1-olein-2,3-dilinolein, 1-palmitin-2,3-dilinolein, 1,3-diolein-2-linolein, 1-palmitin-2-linolein-3-olein, 1,3-dipalmitin-2-linolein, triolein and 1-palmitin-2,3-diolein. The invention also relates to pharmaceutical preparations of this composition and the use thereof in the treatment of tumors and in the immuno-enhancement.
    Type: Application
    Filed: June 8, 2015
    Publication date: January 21, 2016
    Applicants: ZHEJIANG KANGLAITE PHARMACEUTICAL CO., LTD., ZHEJIANG KANGLAITE GROUP CO., LTD.
    Inventor: DAPENG LI
  • Publication number: 20160015768
    Abstract: The present invention relates to Coix seed oil extracted from Semen Coicis, pharmaceutical preparations thereof, and the use thereof in the treatment of tumors and inflammation. Specifically, the Coix seed oil contains 8 triglyceride ingredients in the following mass percentages: trilinolein 4.87-6.99%, 1-olein-2,3-dilinolein 13.00-18.69%, 1-palmitin-2,3-dilinolein 5.25-7.54%, 1,3-diolein-2-linolein 13.23-19.02%, 1-palmitin-2-linolein-3-olein 10.26-14.75%, 1,3-dipalmitin-2-linolein 2.28-3.28%, triolein 14.44-20.76%, and 1-palmitin-2,3-diolein 8.06-11.58%.
    Type: Application
    Filed: June 8, 2015
    Publication date: January 21, 2016
    Applicants: ZHEJIANG KANGLAITE GROUP CO., LTD., ZHEJIANG KANGLAITE PHARMACEUTICAL CO., LTD.
    Inventor: DAPENG LI
  • Publication number: 20160015669
    Abstract: The invention relates to a compound, 1,3-diolein-2-linolein, having a structure of formula (I), which is prepared by a process comprising the preparation of Coix seed oil from the Coix seed powder; the preliminary separation of 1,3-diolein-2-linolein; and the double-separation of 1,3-diolein-2-linolein. The invention also relates to pharmaceutical preparations of 1,3-diolein-2-linolein, and the use of this compound and pharmaceutical preparations thereof in the treatment of tumors.
    Type: Application
    Filed: June 8, 2015
    Publication date: January 21, 2016
    Applicants: ZHEJIANG KANGLAITE GROUP CO., LTD., ZHEJIANG KANGLAITE PHARMACEUTICAL CO., LTD.
    Inventor: DAPENG LI
  • Publication number: 20160015671
    Abstract: The present invention relates to a pharmaceutical composition containing 8 compounds: trilinolein, 1-olein-2,3-dilinolein, 1-palmitin-2,3-dilinolein, 1,3-diolein-2-linolein, 1-palmitin-2-linolein-3-olein, 1,3-dipalmitin-2-linolein, triolein and 1-palmitin-2,3-diolein. The invention also relates to pharmaceutical preparations of this composition and the use thereof in the treatment of tumors and in the immuno-enhancement.
    Type: Application
    Filed: June 8, 2015
    Publication date: January 21, 2016
    Applicants: ZHEJIANG KANGLAITE PHARMACEUTICAL CO., LTD., ZHEJIANG KANGLAITE GROUP CO., LTD.
    Inventor: DAPENG LI
  • Publication number: 20160015769
    Abstract: The present invention relates to Coix seed oil extracted from Semen Coicis, pharmaceutical preparations thereof, and the use thereof in the treatment of tumors and inflammation. Specifically, the Coix seed oil contains 5 diglyceride and 8 triglyceride ingredients in the following mass percentages: 1,3-diolein 0.40-0.58%, 1-linolein-3-olein 0.91-1.31%, 1,2-diolein 0.24-0.35%, 1-olein-2-linolein 0.66-0.95%, 1,2-dilinolein 0.33-0.47%, trilinolein 4.87-6.99%, 1-olein-2,3-dilinolein 13.00-18.69%, 1-palmitin-2,3-dilinolein 5.25-7.54%, 1,3-diolein-2-linolein 13.23-19.02%, 1-palmitin-2-linolein-3-olein 10.26-14.75%, 1,3-dipalmitin-2-linolein 2.28-3.28%, triolein 14.44-20.76% and 1-palmitin-2,3-diolein 8.06-11.58%.
    Type: Application
    Filed: June 8, 2015
    Publication date: January 21, 2016
    Applicants: ZHEJIANG KANGLAITE GROUP CO., LTD., ZHEJIANG KANGLAITE PHARMACEUTICAL CO., LTD.
    Inventor: DAPENG LI